Astract. Oxygen free radicals released during endotoxemia may contribute to the lung injury of the adult respiratory distress syndrome (ARDS). As this syndrome occurs frequently after gram-negative sepsis in humans, we studied the effect ofintravenous N-acetylcysteine (NAC), a free radical scavenger, upon the endotoxin (E)-induced model of ARDS in awake sheep. In vivo studies demonstrated that NAC attenuates the endotoxin-induced rise in pulmonary artery pressure (62±3 torr with E control vs. 43±3 torr for E + NAC), and markedly diminishes the rise in lymph flow at 1 h (8.5±1.2 vs 4.5±0.6 ml/15 min) and 4 h (5.0±0.6 vs. 3.3±0.4 ml/15 min), respectively, for E control vs. E + NAC. NAC also markedly attenuated the alterations in lung mechanics after endotoxemia. Dynamic compliance at 2 h after endotoxemia was 44±6% of base line for E vs. 76±10% of base line for E + NAC. Resistance to airflow across the lung at 1 h postendotoxin was 811±280% of base line for E vs. 391±233% of base line for E + NAC. NAC substantially reduced the 1 h postendotoxin rise in lymph concentrations of thromboxane B2 (8.29±3.28 vs. 2.75±1.93 ng/ ml for E vs. E + NAC) and 6-keto-prostaglandin-Fja (0.91±0.27 vs. 0.23±0.12 ng/ml for E vs. E + NAC). In addition, in vitro studies were performed which revealed NAC to be a potent free radical scavenger in both biologic and nonbiologic free radical generating systems. NAC decreased phorbol-stimulated granulocyte aggregation in a concentration-dependent manner in vitro. Minimal ef-
Introduction
The adult respiratory distress syndrome (ARDS)' is a lung disorder characterized by diffuse bilateral pulmonary infiltrates, decreased lung compliance, and hypoxemia. All of these occur in the absence of heart failure, as defined by a normal pulmonary capillary wedge pressure. The course is frequently one of progressive deterioration of lung function, with death resulting from respiratory failure or a superimposed complication. It is postulated that activated granulocytes and possibly other cells sequestered in the lungs of these patients actively and progressively damage the capillary endothelium, which results in increased vascular permeability, and nonhydrostatically mediated pulmonary edema. As this syndrome frequency occurs in humans after gram-negative sepsis, an animal model of ARDS that uses an infusion of gram-negative bacterial endotoxin has been de-veloped in sheep (1) . In the unanesthetized sheep there is a biphasic response to the endotoxemia. Within 1 h there is an early phase that is characterized by pulmonary hypertension, an increase in the flow of protein-poor lung lymph, and marked alterations of lung mechanics and gas exchange (2) . These changes are prevented by pretreatment with agents that block the cyclooxygenase pathway of arachidonic acid metabolism (3) . Subsequently, there is a late phase response at 3-4 h, which is characterized by the development of pulmonary edema with an increase in the flow of protein-rich lung lymph in spite of normal or near normal pulmonary artery and left atrial pressures, and improving but still impaired lung mechanics and gas exchange.
Previous studies have suggested that granulocytes are important mediators of the late phase changes, and possibly contribute to the early phase abnormalities as well. Evidence for this is threefold. First, histologic studies reveal granulocyte sequestration in the lung after endotoxemia associated with endothelial cell damage (4) . Secondly, granulocyte-depleted sheep have a markedly blunted late phase (5) , and an attenuation of the early phase alterations in lung mechanics (6) . Finally, phorbol myristate acetate (PMA), a known granulocyte activator, is capable of producing a similar biphasic response (7, 8) . The mechanisms by which granulocytes contribute to these changes are not fully understood but may relate to their ability to release a variety of oxygen radicals, including the superoxide anion (O2), singlet oxygen, and hydroxyl radicals (OHS and HOCr).
Free radical-generating systems are capable of producing endothelial cell damage in vitro (9, 10) . Activated granulocytes and tissue macrophages are also capable of generating oxygen free radicals, thereby raising the possibility that these cells contribute to acute lung injury (1 1, 12) . Endothelial cell damage in in vitro models can be blocked by the addition of enzymes or free radical scavengers, such as catalase (10, 13, 14) , superoxide dismutase (12, 15, 16) , dimethyl sulfoxide (17, 18) , and dimethylthiourea (10, 19, 20) . These agents work by differing mechanisms but the latter two contain sulfhydryl groups that are thought capable of scavenging free radicals.
NAC has been used extensively and successfully in humans in the treatment of acetaminophen (paracetamol) toxicity (21) . Acetaminophen itself is not toxic, but the metabolism of acetaminophen by the liver involves the production of small amounts of hydroxylated free radicals, which can bind covalently to hepatic proteins. These highly reactive radicals will preferentially bind to glutathione, thereby converting it to a nontoxic conjugate of cysteine, but the detoxifying mechanisms can be exhausted ifcysteine or glutathione stores are depleted (22) . The sulfhydryl bond of cysteine seems to be the important element because similar results have been obtained with methionine and cysteamine (23, 24) . These compounds, along with NAC, are thought to work by providing substrate to replenish glutathione stores, or by competitively binding directly to the free radical species. Because In vitro studies. WBC were harvested from chronically instrumented but otherwise healthy sheep, which had not been experimented upon within 48 h. 30 ml of whole blood in 1,000 U heparin was layered over 15 ml of Ficoll-Hypaque in a 50-ml polypropylene tube (Histopaque, Sigma Chemical Co.) and centrifuged at 400 rpm for 40 min and allowed to stop with the brake off. The resultant plasma layer and top threefourths ofthe Ficoll-Hypaque layer was discarded. The granulocyte layer was then aspirated and resuspended in a hypotonic lysing solution consisting of 8.9 g NH4C1, 1.0 g KHCO3, and 30 mg EDTA per liter of distilled water. This was allowed to react for 5 min before resedimenting the remaining cells at 200 rpm for 5 min. The cells were then washed in 0.9 N NaCl solution before being suspended in Hanks' balanced salt solution (BSS) with Ca"+ and Mg"+ at a final concentration of 1 X 107 cells/ml. The cells were routinely >95% viable by trypan blue dye exclusion, and consisted of -80-90% granulocytes. No erythrocytes or platelets were seen at the time of counting.
Measurement of aggregation. Aggregation studies were performed with a Payton Dual Channel model 300 BD Aggregometer coupled with a Dual Pen Recorder, model 585 (Linear Instruments Corp., Reno, NV). The aggregometer was set at 370C, 400 rpm's, level 0.5, and a range of four. The recorder was set at 50 mV and a paper speed of 1 cm/min. 350 Ml of leukocyte suspension was placed in a small siliconed glass cuvette with a stir bar, inserted in the aggregometer, and allowed to reach 370C. The aggregometer was then standardized by setting the light transmittance to 0% on the paper recorder using the zero control, then replacing the cell cuvette with one containing only Hanks' physiologic buffered saline and a stir bar and adjusting the output level to 100% light transmittance. The cell cuvette was then placed back into the aggregometer and the cells were stimulated with 50 td ofeither PMA (40 ng/ml final concentration) or zymosan-activated plasma (ZAP, full strength). To determine the effect of NAC upon aggregation, the leukocytes were suspended in NAC (variable concentrations) and either incubated at 37°C for 30 min, or stimulated immediately. The results are reported as the maximum percent change in light transmittance (%).
Measurements of chemiluminescence. Free radical production was measured by chemiluminescence (31) as NAC was found to spontaneously reduce cytochrome C, which made that assay invalid. The biologic system consisted of a leukocyte suspension (4 ml) in Hanks' BSS (2.5 X 106 cells/ml final concentration), which was stimulated with either PMA (40 ng/ml final concentration) or ZAP (10%) with and without the presence of NAC (2.8 mg/ml). The nonbiologic system consisted of 3,150 ,ul of xanthine solution (xanthine, 12 mg; EDTA, 5 mg; Hepes solution, 12 gl; all in 250 ml 0.9 N saline), 400 ul human plasma, and 400 ,l of either Hanks' BSS or NAC (2.8 mg/ml final concentration) in BSS. The reaction was initiated by the addition of 50 Ml of xanthine oxidase solution (0.96 U/ml). All Release of lysozyme from human granulocytes, prepared in an identical fashion as for sheep cells, was assayed as described by Gordon et al. (34) . The decrease in turbidity of a suspension of Micrococcus lysodeckticus caused by supernatants of granulocytes at rest and exposed to PMA or ZAP with or without preincubation with NAC (2.8 mg/ml) as described in the ,B-glucuronidase section, was determined by continuous spectrophotometric recording at 540 nm. Results are expressed as the percentage of total lysozyme content, which was determined using supernatants of granulocytes lysed with Triton X-100.
In vivo experimental protocol. After 6-7 d postoperative recovery time, 10 yearling sheep were studied awake and standing in the plethysmograph. The sheep received either endotoxin (E) alone or in combination with NAC in random order on separate days, which was followed by a third study consisting of NAC alone. The sheep were allowed 3-4 d recovery time between each experiment.
For all experiments, stable values (±10%) of vascular pressures, lymph flow, and lung mechanics were obtained for at least I h (four measurements) as a base line. for the E-control experiment, the sheep then received an intravenous infusion of 200 ml of 5% dextrose in water (D5W) over 1 h as the vehicle control, followed by another 50 ml D5W over the subsequent hour. Escherichia coli endotoxin (055:B5), 1 4g/ ml in D5W, was then infused via a central line at a dose of 0.2-0.5 jig/ kg over 15 min. The sheep continued to receive D5W intravenously at a rate of 50 ml/h for the next 4 h until the experiment was completed.
In the combined NAC-plus-E experiments, after base line, the sheep received NAC intravenously in a loading dose of 150 mg/kg in 200 ml D5W over 1 h, followed by a maintenance dose of 20 mg/kg in 50 ml D5W each hour for 5 h until the experiment was ended. After the first hour of maintenance NAC infusion, the sheep received E in an identical manner as described above. An identical dose of E was given to the sheep for both the E-control and NAC-plus-E experiments.
The NAC-control experiments were carried out similarly to the NACplus-E experiments, only the E was omitted. The animals were given 3-5 d between each experiment to recover. All sheep received both E and combined NAC-plus-E experiments, while only six sheep received the NAC-control experiment. Ofthese six sheep, only three had a patent lymph cannula on the day of the NAC study. Lung mechanics also were obtained on only three sheep during the NAC-control experiment, while hemodynamic measurements were obtained on all NAC-control sheep.
Statistics. Physiologic data are presented as the mean value±standard error. To test statistical significance of differences over time in each of the three groups, E-plus-vehicle, E-plus-NAC, and NAC alone, and to test the significance of differences between groups, we used a split-plot design with randomized complete blocks for three-way analysis of variance. The null hypothesis was rejected for P < 0.05. Kramer's adaptation of Duncan's Multiple range test (35) was then used to test for significance of differences within groups at the P < 0.05 level. The in vitro data were analyzed by the paired t test at the P < 0.05 level. The null hypothesis was rejected for P < 0.05.
Results
Endotoxin response. E alone caused a marked increase in the pulmonary artery mean pressure (PpA) reaching a peak from 30 to 45 min after endotoxemia before decreasing rapidly, reaching base line values by the third hour postendotoxemia (Table I, The lung lymph was also markedly altered in response to E. The lymph flow (QL) increased significantly by 1 h postendotoxemia. It then decreased gradually but remained significantly elevated at 4 h after endotoxin. The lymph-to-plasma protein (L/P) ratio fell significantly at 1 h postendotoxemia. By 4 h postendotoxin the L/P ratio had increased and was slightly although not significantly greater than at base line. When the data were expressed as the clearance of lung lymph protein, C1p (QL X L/P), the C1p increased significantly by I h post-E, and remained elevated throughout the experiment (Fig. 2) .
Endotoxin also produced marked alterations in lung mechanics (Table II) . The Cdyn fell markedly by I h post-E, then improved slightly over the next hour before falling again. Cdyn remained significantly depressed at 4 h. Likewise, RL increased markedly I h postendotoxemia, but then decreased rapidly over the ensuing 2 h, plateauing at a level slightly higher than the original base line, although not significantly so (Fig. 3) . The FRC was not altered significantly by endotoxemia.
Gas exchange, as expressed by AAaPO2, worsened after endotoxemia, and reached a nadir at 1 h post-E. This improved with time and was not significantly greater than base line at 4 h post-E (Fig. 4) . For reasons that are unclear, the base-line value for this experiment is higher than with the other two experiments (NAC-plus-E; NAC alone). Nonetheless, the AXAaPO2 in these sheep worsened with E similarly to experiments previously reported from this laboratory (2, 3).
The peripheral WBC count fell dramatically with endotox- Finally, E infusion produced a marked increase in lung lymph TxB2 levels at I h, as seen in Fig. 6 . Similarly, the 6-keto-PGFI,, levels were increased at I h, while neither the TxB2 nor 6-ketoPGFIa levels were significantly different from base line by 4 h post-E (Table III) . NAC-plus-endotoxin. Treatment with NAC before the administration ofE attenuated all ofthe above abnormalities caused by E alone. The pulmonary hypertensive response was significantly blunted as was the increase in PVR post-E, although there were no changes in the timing of the response as seen with E alone. However, NAC completely prevented the decrease in cardiac output observed with E alone (Fig. 1, Table 1 ).
Lymph flow at ½/2 h post-E was significantly less with NACplus-E as compared with E alone. The QL then decreased gradually with time; similar to E alone, but unlike with E control, it was not significantly different from base line at the fourth hour post-E. The L/P ratio at 1 h post-E did not fall significantly with NAC-plus-E, but tended to be elevated at 4 h, though not significantly. Consequently, C1p was significantly lower 1 h post-E with NAC-plus-E than with E alone. The Cp remained significantly lower throughout the observation period with NAGplus-E than with E alone (Fig. 2, Table I ).
Lung mechanics were also less affected with NAC-plus-E than with E alone. Cdyn decreased significantly less, and RL increased significantly less at 1 h post-E when NAC was present, than with E alone (Fig. 3 , Table II ). 2 h post-E, the differences (Fig. 3) . The peripheral WBC count fell 1 h post-E when NAC was present, though significantly less so than for E alone (5,934±1,320 cells/mm3 vs. 2,306±481 cells/mm3, respectively). This effect persisted even when the counts were expressed as percentage of base line. Further, the recovery from E-induced neutropenia was more rapid when NAC was present, (4 h WBC -12,322±3,326 cell/mm3 with E-plus-NAC as compared with 6,732±1,465 cells/mm3 with E alone) (Fig. 5) .
Finally, there was a pronounced effect of NAC upon lung lymph TxB2 and 6-keto-PGF1,, levels. The rise in TxB2 and 6-keto-PGF,,, levels seen 1 h after endotoxemia was significantly less for NAC-plus-E than with E alone in all sheep. Concentrations of TxB2 and 6-keto-PGF14 in the NAC-plus-E experiments were not significantly different from the base-line value either at 1 or 4 h post-E (Table III, Fig. 6 ).
NAC alone. None of the measured variables changed significantly during the infusion of NAC alone except for AAaPO2 and peripheral WBC count. The AAaPO2 significantly worsened after NAC in both the NAC alone and in the pre-E portion of the NAC-plus-E experiments (Fig. 4) . There was, however, no alteration of either CdY, or RL after NAC (Fig. 3) .
The peripheral WBC count increased dramatically after NAC alone (Fig. 5 ). This progressed with time and was accompanied by an increase in the percentage of circulating immature granulocytes.
In vitro leukocyte studies. NAC was found to have a dosedependent effect upon leukocyte aggregation as seen in Fig. 7 per minute for the control xanthine-plus-Hanks' BSS TIME (hours) (76,049±713 cpm) than did the xanthine-plus-NAC reaction of NAC on E-induced changes in the alveolar-to-arte- (19,787±683 cpm) . Control experiments were performed by sure difference. Data points represent the measuring uric acid concentrations as an end-product. Equal = 10 for E-plus-vehicle and E-plus-NAC; n = 4 for amounts of xanthine were converted to uric acid whether or he data from the E-plus-vehicle are represented by .; not NAC was present in the system, which indicates that NAC ie E-plus-NAC experiments are represented by o; and did not directly inhibit the xanthine-xanthine oxidase enzyme. ie NAC-control experiments are represented by C. * Both reactions generated significantly (P < 0.05) more chee data point is significantly different (P < 0.05) from miluminescence than did the nonstimulated base-line systems.
I, base line. T indicates that the data point is significantly different (P < 0.05) from the time-matched E-plus-NAC data point. t indicates that the base-line data point is significantly different (P < 0.05) from the time-matched E-plus-NAC base-line data point.
Discussion
In the sheep model of endotoxin-induced ARDS we have shown that NAC, when delivered before, during, and continuing after not preincubated with NAC but rather stimulated immediately after the addition of NAC. The attenuation of aggregation may represent a cytotoxic effect of NAC upon leukocytes as trypan blue dye studies revealed excessive uptake by cells incubated with NAC (1 X 10-' M) for 3 h as compared with cells similarly incubated with Hanks' BSS. Such changes were not, however, seen at lower doses of NAC and for shorter incubation periods.
Assuming that NAC was entirely limited to the circulating blood volume and was neither excreted nor metabolized, the maximum calculated concentration of NAC that was achieved during the in vivo tests was 2.8 mg/ml (1.7 X 1O-2 M). At this concentration of NAC, and when preincubated with leukocytes in vitro at 370C for 30 min, there was a slight but significant (P < 0.05) decrease in aggregation in response to both PMA and ZAP (Table IV) .
In contrast, NAC potentiated leukocyte degranulation.
Azurophilic degranulation, as measured by f3-glucuronidase activity from sheep granulocytes, was found to be slightly potentiated (P < 0.05) by the preincubation of cells with NAC when stimulated with ZAP (Table IV) . Degranulation by resting cells was also slightly enhanced by NAC but PMA was found not to cause azurophilic degranulation as is also the case in human cells (36). Specific granule release was studied in human cells (n = 6) as sheep cells do not contain lysozyme (32) . There were no significant differences (P < 0. Figure 5 . Effect of NAC on the peripheral WBC count. Data points are represented as the mean±SEM. n = 9 for E-plus-vehicle and Eplus-NAC; n = 6 for NAC control. The data points for E-plus-vehicle experiments are represented by *; the data points for E-plus-NAC experiments are represented by o; and the data points for NAC-control experiments are represented as C. * indicates the data point is significantly different (P < 0.05) from base line. t indicates that the E-plusvehicle data point is significantly different (P < 0.05) from the timematched E-plus-NAC data point. t indicates that the NAC-control data point is significantly different (P < 0.05) from either the E-plusvehicle or E-plus-NAC time-matched data points. f indicates that the NAC-control data point is significantly different (P < 0.05) from the time-matched E-plus-vehicle data point. lymph Tx B2 and 6-keto-PG Fl. levels. Data represent the mean±SEM. n = 7 for E-plus-vehicle and E-plus-NAC; n = 3 for NAC control. * indicates that the data are significantly different (P < 0.05) from base line. t indicates that the data are significantly different (P < 0.05) from either the E-plusvehicle or E-plus-NAC time-matched data.
an infusion ofendotoxin, is capable ofattenuating all measured pathophysiologic changes. NAC attenuated the early-phase rise in pulmonary artery pressure, and the increase in PVR, and prevented the decrease in cardiac output associated with endotoxemia. These findings, supported by the marked attenuation of the E-induced rise in TxB2 and 6-keto-PGFI., suggest that NAC interfered in the usual post-E cascade ofevents that lead to increased arachidonic with NAC + AA). This pressure increase seen with arachidonate infusion is felt to be secondary to the conversion of AA to prostaglandin exdoperoxides through the cyclooxygenase pathway and is inhibited by cyclooxygenase inhibitors (38) . The effect of NAC on phospholipase A is unknown, though an inhibitory effect on this enzyme would be compatible with our data. Alternatively, and consistent with our hypothesis, NAC may work by decreasing cell membrane damage and the attendant release of phospholipids.
NAC also markedly blunted both the early-and late-phase increase in lung lymph flow. The early-phase attenuation is probably accounted for in part by the accompanying attenuation of the early phase pulmonary hypertension. However, the decrease in lymph flow seen in the animals treated with NAC is out of proportion to that expected to occur for the corresponding drop in pulmonary pressure. This is readily explained if permeability alterations begin to occur during the early phase. Support for the latter concept is found in studies using cyclooxygenase inhibitors in which there persists a significant increase in lymph flow by as early as 1 h post-E, despite only a mild rise in pulmonary artery pressure (3). In addition, histologic studies have revealed electron microscopic evidence of endothelial cell damage by 30 min post-E, although light microscopy does not reveal edema formation until 2 h after endotoxin (4). Thus, it is possible that microvascular permeability increases early in response to endotoxemia, and that NAC attenuated this pathological response. Further support for the ability of NAC to attenuate E-induced permeability changes is found in the late (3-4 h) phase response, where there is a high relatively protein-rich lymph flow, which has been associated with frank nonhydrostatic pulmonary edema (2) .
Although this study was not designed to address the mechanism of the observed alterations in lung function, it is clear from other studies in our laboratory that granulocyte depletion can attenuate the sheep's airway response to E (6). It is conceivable that granulocytes contribute to the altered lung mechanics either by inducing vascular and/or airway damage directly, or by initiating the production of mediators that subsequently produce bronchospasm. The former postulate seems unlikely as the physiologic alterations in lung mechanics occur before the demonstration of marked histologic changes; although physiologic changes can precede histologic changes. This suggests that NAC interferes with either the production, release, or action of the proposed bronchospastic mediators. Of these possible mechanisms the first two would be consistent with the concept that NAC attenuates endothelial cell damage, which was suggested by the other data presented here. An antagonism of the bronchospastic mediators or a direct beneficial effect by NAC upon airway function can not be excluded by our data, but seems unlikely. NAC is not a bronchodilator, but rather can induce bronchospasm when given as an aerosol. In this study we found a reproducible deterioration in gas exchange when NAC was infused, but no alteration in lung mechanics. The etiology of the widened AAaPO2 is unknown.
While it is clear that NAC at high concentrations (1 X 10-2 M) can have cytotoxic effects (independent of pH) upon sheep leukocytes as seen in both aggregation and enzyme release studies, it is unlikely that such concentrations were achieved in vivo. NAC has a small molecular weight and has relatively free access to all body tissue fluids. The plasma half-life of NAC has been estimated to be -80 min. NAC in the plasma appears to be in an equilibrium between free drug and that bound to albumin and body proteins <38, 39). Under normal conditions then, NAC may be excreted via the kidneys only slowly, while under conditions of oxidant stress, it is readily metabolized by cells via the glutathione reductase pathway and the metabolites are rapidly excreted via the kidneys. Thus, it is likely that the NAC concentration to which the leukocytes were exposed in vivo is much less than the 1.7 X 10-2 M (2.8 mg/ml) concentration used during the in vitro experiments. Our data suggest that NAC did not reach high enough concentrations in vivo to affect leukocyte aggregation or degranulation.
Adherence has been shown to be vital in the leukocytes' ability to produce endothelial cell damage-possibly due to the short half-life of the oxygen free radical. Aggregation and adherence phenomena seem to be similar functions of the leukocyte, but subtle differences in extracellular cation requirements are known to exist (40, 41) In the in vitro studies, the reduction in chemiluminescence produced by granulocytes stimulated with either ZAP or PMA in the presence of NAC is consistent with either a decreased cellular release of oxygen free radicals or a scavenging effect upon these radicals once they were released. The ability ofNAC to also attenuate chemiluminescence ofa nonbiologic free radical generating system suggests that NAC is a direct free radical scavenger. Whether NAC also works to decrease cytotoxic effects of free radicals by an enhancement of the cell's cytoplasmic defense systems through replenishment of glutathione and cysteine stores is not known.
Finally, the inability of NAC to interfere with leukocyte degranulation in vitro is significant from a pathophysiologic standpoint because this suggests that NAC did not interfere with in vivo proteolytic enzyme release or function. The relative role ofoxygen free radicals vs. activated enzymes in producing granulocyte-mediated endothelial cell damage in vivo is unclear. However, in vitro studies reveal that free radicals alone are capable of producing endothelial cell damage (9, 10 animal model of the adult respiratory syndrome is due to its ability to scavenge oxygen free radicals in vivo. There has been, however, no direct measurement of the extent to which these free radicals are actually released in this model of ARDS. In addition, enhancement of cytoplasmic defenses against oxidant injury and a reduction of leukocyte adherence or chemotaxis remain as alternative explanations of NAC's beneficial effects. That NAC does not completely abolish all pathophysiologic responses to endotoxemia could be due to dosage or distribution factors, as well as to the complexity of the endotoxin response, which may involve multiple pathological pathways. While we are encouraged by the relative safety of intravenous NAC, and its potential role in ARDS or other disease states involving oxygen free radicals, we feel that further documentation of its beneficial effect is required before it can be recommended for clinical studies.
